Global Circulating Tumor Cells Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Publisher Name :
Date: 10-Sep-2018
No. of pages: 152

Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.

Scope of the Report:

This report studies the Circulating Tumor Cells market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Circulating Tumor Cells market by product type and applications/end industries.

The classification of Circulating Tumor Cells (CTCs) products includes CTC enrichment, CTC detection and CTC analysis, and the revenue proportion of CTC enrichment in 2016 is about 43.74%.

North America is the largest supplier of CTCs Products, with a revenue market share nearly 53.18% in 2016. Europe is the second largest supplier of CTCs products, enjoying revenue market share nearly 28.01% in 2016.

Growth of the global CTCs market is mainly driven by increasing prevalence of cancer globally. Increasing prevalence of various cancers such as breast cancer, prostate cancer and lung cancer is expected to drive growth of the CTCs test market over the forecast period.

FDA approvals for various non-invasive diagnostic tests to detect cancer are set to define the regulatory landscape for CTCs tests. Companies in the CTCs market space are expected to invest more on test kits and cost containment procedures to provide innovative diagnostic solutions to the oncologists and physicians for detecting metastasis.

The global Circulating Tumor Cells market is valued at 1220 million USD in 2017 and is expected to reach 2740 million USD by the end of 2023, growing at a CAGR of 14.5% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Circulating Tumor Cells.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

- Menarini-Silicon Biosystems

- Qiagen(Adnagen)

- Clearbridge Biomedics

- Celsee

- Fluidigm

- ApoCell

- Greiner Bio-one GmbH

- Advanced Cell Diagnostics

- Aviva Biosciences

- Fluxion Biosciences

- Sysmex Corporation

- Epic Sciences

- Cynvenio

- CytoTrack

- Ikonisys

- Vortex BioSciences

- Gilupi

- Biocept

- ScreenCell

- ANGLE

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- CTC Enrichment

- CTC Detection

- CTC Analysis

Market Segment by Applications, can be divided into

- Breast Cancer

- Prostate Cancer

- Colorectal Cancer

- Other

Global Circulating Tumor Cells Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Table of Contents
1 Circulating Tumor Cells Market Overview
1.1 Product Overview and Scope of Circulating Tumor Cells
1.2 Classification of Circulating Tumor Cells by Types
1.2.1 Global Circulating Tumor Cells Revenue Comparison by Types (2017-2023)
1.2.2 Global Circulating Tumor Cells Revenue Market Share by Types in 2017
1.2.3 CTC Enrichment
1.2.4 CTC Detection
1.2.5 CTC Analysis
1.3 Global Circulating Tumor Cells Market by Application
1.3.1 Global Circulating Tumor Cells Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Colorectal Cancer
1.3.5 Other
1.4 Global Circulating Tumor Cells Market by Regions
1.4.1 Global Circulating Tumor Cells Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Circulating Tumor Cells Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Circulating Tumor Cells Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Circulating Tumor Cells Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Circulating Tumor Cells Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Circulating Tumor Cells Status and Prospect (2013-2023)
1.5 Global Market Size of Circulating Tumor Cells (2013-2023)
2 Manufacturers Profiles
2.1 Menarini-Silicon Biosystems
2.1.1 Business Overview
2.1.2 Circulating Tumor Cells Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.2 Qiagen(Adnagen)
2.2.1 Business Overview
2.2.2 Circulating Tumor Cells Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Qiagen(Adnagen) Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.3 Clearbridge Biomedics
2.3.1 Business Overview
2.3.2 Circulating Tumor Cells Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Clearbridge Biomedics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.4 Celsee
2.4.1 Business Overview
2.4.2 Circulating Tumor Cells Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Celsee Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.5 Fluidigm
2.5.1 Business Overview
2.5.2 Circulating Tumor Cells Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Fluidigm Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.6 ApoCell
2.6.1 Business Overview
2.6.2 Circulating Tumor Cells Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 ApoCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.7 Greiner Bio-one GmbH
2.7.1 Business Overview
2.7.2 Circulating Tumor Cells Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Greiner Bio-one GmbH Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.8 Advanced Cell Diagnostics
2.8.1 Business Overview
2.8.2 Circulating Tumor Cells Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Advanced Cell Diagnostics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.9 Aviva Biosciences
2.9.1 Business Overview
2.9.2 Circulating Tumor Cells Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Aviva Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.10 Fluxion Biosciences
2.10.1 Business Overview
2.10.2 Circulating Tumor Cells Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Fluxion Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.11 Sysmex Corporation
2.11.1 Business Overview
2.11.2 Circulating Tumor Cells Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Sysmex Corporation Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.12 Epic Sciences
2.12.1 Business Overview
2.12.2 Circulating Tumor Cells Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Epic Sciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.13 Cynvenio
2.13.1 Business Overview
2.13.2 Circulating Tumor Cells Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Cynvenio Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.14 CytoTrack
2.14.1 Business Overview
2.14.2 Circulating Tumor Cells Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 CytoTrack Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.15 Ikonisys
2.15.1 Business Overview
2.15.2 Circulating Tumor Cells Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Ikonisys Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.16 Vortex BioSciences
2.16.1 Business Overview
2.16.2 Circulating Tumor Cells Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Vortex BioSciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.17 Gilupi
2.17.1 Business Overview
2.17.2 Circulating Tumor Cells Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Gilupi Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.18 Biocept
2.18.1 Business Overview
2.18.2 Circulating Tumor Cells Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Biocept Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.19 ScreenCell
2.19.1 Business Overview
2.19.2 Circulating Tumor Cells Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 ScreenCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.20 ANGLE
2.20.1 Business Overview
2.20.2 Circulating Tumor Cells Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 ANGLE Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
3 Global Circulating Tumor Cells Market Competition, by Players
3.1 Global Circulating Tumor Cells Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Circulating Tumor Cells Players Market Share
3.2.2 Top 10 Circulating Tumor Cells Players Market Share
3.3 Market Competition Trend
4 Global Circulating Tumor Cells Market Size by Regions
4.1 Global Circulating Tumor Cells Revenue and Market Share by Regions
4.2 North America Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
4.3 Europe Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
4.5 South America Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
5 North America Circulating Tumor Cells Revenue by Countries
5.1 North America Circulating Tumor Cells Revenue by Countries (2013-2018)
5.2 USA Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
5.3 Canada Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
5.4 Mexico Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
6 Europe Circulating Tumor Cells Revenue by Countries
6.1 Europe Circulating Tumor Cells Revenue by Countries (2013-2018)
6.2 Germany Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
6.3 UK Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
6.4 France Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
6.5 Russia Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
6.6 Italy Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Circulating Tumor Cells Revenue by Countries
7.1 Asia-Pacific Circulating Tumor Cells Revenue by Countries (2013-2018)
7.2 China Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
7.3 Japan Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
7.4 Korea Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
7.5 India Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
8 South America Circulating Tumor Cells Revenue by Countries
8.1 South America Circulating Tumor Cells Revenue by Countries (2013-2018)
8.2 Brazil Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
8.3 Argentina Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
8.4 Colombia Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Circulating Tumor Cells by Countries
9.1 Middle East and Africa Circulating Tumor Cells Revenue by Countries (2013-2018)
9.2 Saudi Arabia Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
9.3 UAE Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
9.4 Egypt Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
9.5 Nigeria Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
9.6 South Africa Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
10 Global Circulating Tumor Cells Market Segment by Type
10.1 Global Circulating Tumor Cells Revenue and Market Share by Type (2013-2018)
10.2 Global Circulating Tumor Cells Market Forecast by Type (2018-2023)
10.3 CTC Enrichment Revenue Growth Rate (2013-2023)
10.4 CTC Detection Revenue Growth Rate (2013-2023)
10.5 CTC Analysis Revenue Growth Rate (2013-2023)
11 Global Circulating Tumor Cells Market Segment by Application
11.1 Global Circulating Tumor Cells Revenue Market Share by Application (2013-2018)
11.2 Circulating Tumor Cells Market Forecast by Application (2018-2023)
11.3 Breast Cancer Revenue Growth (2013-2018)
11.4 Prostate Cancer Revenue Growth (2013-2018)
11.5 Colorectal Cancer Revenue Growth (2013-2018)
11.6 Other Revenue Growth (2013-2018)
12 Global Circulating Tumor Cells Market Size Forecast (2018-2023)
12.1 Global Circulating Tumor Cells Market Size Forecast (2018-2023)
12.2 Global Circulating Tumor Cells Market Forecast by Regions (2018-2023)
12.3 North America Circulating Tumor Cells Revenue Market Forecast (2018-2023)
12.4 Europe Circulating Tumor Cells Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Circulating Tumor Cells Revenue Market Forecast (2018-2023)
12.6 South America Circulating Tumor Cells Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Circulating Tumor Cells Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Circulating Tumor Cells Picture
Table Product Specifications of Circulating Tumor Cells
Table Global Circulating Tumor Cells and Revenue (Million USD) Market Split by Product Type
Figure Global Circulating Tumor Cells Revenue Market Share by Types in 2017
Figure CTC Enrichment Picture
Figure CTC Detection Picture
Figure CTC Analysis Picture
Table Global Circulating Tumor Cells Revenue (Million USD) by Application (2013-2023)
Figure Circulating Tumor Cells Revenue Market Share by Applications in 2017
Figure Breast Cancer Picture
Figure Prostate Cancer Picture
Figure Colorectal Cancer Picture
Figure Other Picture
Table Global Market Circulating Tumor Cells Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2013-2023)
Table Menarini-Silicon Biosystems Basic Information, Manufacturing Base and Competitors
Table Menarini-Silicon Biosystems Circulating Tumor Cells Type and Applications
Table Menarini-Silicon Biosystems Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Qiagen(Adnagen) Basic Information, Manufacturing Base and Competitors
Table Qiagen(Adnagen) Circulating Tumor Cells Type and Applications
Table Qiagen(Adnagen) Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Clearbridge Biomedics Basic Information, Manufacturing Base and Competitors
Table Clearbridge Biomedics Circulating Tumor Cells Type and Applications
Table Clearbridge Biomedics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Celsee Basic Information, Manufacturing Base and Competitors
Table Celsee Circulating Tumor Cells Type and Applications
Table Celsee Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Fluidigm Basic Information, Manufacturing Base and Competitors
Table Fluidigm Circulating Tumor Cells Type and Applications
Table Fluidigm Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table ApoCell Basic Information, Manufacturing Base and Competitors
Table ApoCell Circulating Tumor Cells Type and Applications
Table ApoCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Greiner Bio-one GmbH Basic Information, Manufacturing Base and Competitors
Table Greiner Bio-one GmbH Circulating Tumor Cells Type and Applications
Table Greiner Bio-one GmbH Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Advanced Cell Diagnostics Basic Information, Manufacturing Base and Competitors
Table Advanced Cell Diagnostics Circulating Tumor Cells Type and Applications
Table Advanced Cell Diagnostics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Aviva Biosciences Basic Information, Manufacturing Base and Competitors
Table Aviva Biosciences Circulating Tumor Cells Type and Applications
Table Aviva Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Fluxion Biosciences Basic Information, Manufacturing Base and Competitors
Table Fluxion Biosciences Circulating Tumor Cells Type and Applications
Table Fluxion Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Sysmex Corporation Basic Information, Manufacturing Base and Competitors
Table Sysmex Corporation Circulating Tumor Cells Type and Applications
Table Sysmex Corporation Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Epic Sciences Basic Information, Manufacturing Base and Competitors
Table Epic Sciences Circulating Tumor Cells Type and Applications
Table Epic Sciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Cynvenio Basic Information, Manufacturing Base and Competitors
Table Cynvenio Circulating Tumor Cells Type and Applications
Table Cynvenio Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table CytoTrack Basic Information, Manufacturing Base and Competitors
Table CytoTrack Circulating Tumor Cells Type and Applications
Table CytoTrack Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Ikonisys Basic Information, Manufacturing Base and Competitors
Table Ikonisys Circulating Tumor Cells Type and Applications
Table Ikonisys Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Vortex BioSciences Basic Information, Manufacturing Base and Competitors
Table Vortex BioSciences Circulating Tumor Cells Type and Applications
Table Vortex BioSciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Gilupi Basic Information, Manufacturing Base and Competitors
Table Gilupi Circulating Tumor Cells Type and Applications
Table Gilupi Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Biocept Basic Information, Manufacturing Base and Competitors
Table Biocept Circulating Tumor Cells Type and Applications
Table Biocept Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table ScreenCell Basic Information, Manufacturing Base and Competitors
Table ScreenCell Circulating Tumor Cells Type and Applications
Table ScreenCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table ANGLE Basic Information, Manufacturing Base and Competitors
Table ANGLE Circulating Tumor Cells Type and Applications
Table ANGLE Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Global Circulating Tumor Cells Revenue (Million USD) by Players (2013-2018)
Table Global Circulating Tumor Cells Revenue Share by Players (2013-2018)
Figure Global Circulating Tumor Cells Revenue Share by Players in 2016
Figure Global Circulating Tumor Cells Revenue Share by Players in 2017
Figure Global Top 5 Players Circulating Tumor Cells Revenue Market Share in 2017
Figure Global Top 10 Players Circulating Tumor Cells Revenue Market Share in 2017
Figure Global Circulating Tumor Cells Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Circulating Tumor Cells Revenue (Million USD) by Regions (2013-2018)
Table Global Circulating Tumor Cells Revenue Market Share by Regions (2013-2018)
Figure Global Circulating Tumor Cells Revenue Market Share by Regions (2013-2018)
Figure Global Circulating Tumor Cells Revenue Market Share by Regions in 2017
Figure North America Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Europe Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure South America Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Table North America Circulating Tumor Cells Revenue by Countries (2013-2018)
Table North America Circulating Tumor Cells Revenue Market Share by Countries (2013-2018)
Figure North America Circulating Tumor Cells Revenue Market Share by Countries (2013-2018)
Figure North America Circulating Tumor Cells Revenue Market Share by Countries in 2017
Figure USA Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Canada Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Mexico Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Table Europe Circulating Tumor Cells Revenue (Million USD) by Countries (2013-2018)
Figure Europe Circulating Tumor Cells Revenue Market Share by Countries (2013-2018)
Figure Europe Circulating Tumor Cells Revenue Market Share by Countries in 2017
Figure Germany Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure UK Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure France Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Russia Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Italy Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Circulating Tumor Cells Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Circulating Tumor Cells Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Circulating Tumor Cells Revenue Market Share by Countries in 2017
Figure China Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Japan Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Korea Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure India Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Table South America Circulating Tumor Cells Revenue by Countries (2013-2018)
Table South America Circulating Tumor Cells Revenue Market Share by Countries (2013-2018)
Figure South America Circulating Tumor Cells Revenue Market Share by Countries (2013-2018)
Figure South America Circulating Tumor Cells Revenue Market Share by Countries in 2017
Figure Brazil Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Argentina Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Colombia Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Circulating Tumor Cells Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Circulating Tumor Cells Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Circulating Tumor Cells Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Circulating Tumor Cells Revenue Market Share by Countries in 2017
Figure Saudi Arabia Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure UAE Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Egypt Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Nigeria Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure South Africa Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Table Global Circulating Tumor Cells Revenue (Million USD) by Type (2013-2018)
Table Global Circulating Tumor Cells Revenue Share by Type (2013-2018)
Figure Global Circulating Tumor Cells Revenue Share by Type (2013-2018)
Figure Global Circulating Tumor Cells Revenue Share by Type in 2017
Table Global Circulating Tumor Cells Revenue Forecast by Type (2018-2023)
Figure Global Circulating Tumor Cells Market Share Forecast by Type (2018-2023)
Figure Global CTC Enrichment Revenue Growth Rate (2013-2018)
Figure Global CTC Detection Revenue Growth Rate (2013-2018)
Figure Global CTC Analysis Revenue Growth Rate (2013-2018)
Table Global Circulating Tumor Cells Revenue by Application (2013-2018)
Table Global Circulating Tumor Cells Revenue Share by Application (2013-2018)
Figure Global Circulating Tumor Cells Revenue Share by Application (2013-2018)
Figure Global Circulating Tumor Cells Revenue Share by Application in 2017
Table Global Circulating Tumor Cells Revenue Forecast by Application (2018-2023)
Figure Global Circulating Tumor Cells Market Share Forecast by Application (2018-2023)
Figure Global Breast Cancer Revenue Growth Rate (2013-2018)
Figure Global Prostate Cancer Revenue Growth Rate (2013-2018)
Figure Global Colorectal Cancer Revenue Growth Rate (2013-2018)
Figure Global Other Revenue Growth Rate (2013-2018)
Figure Global Circulating Tumor Cells Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Circulating Tumor Cells Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Circulating Tumor Cells Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Circulating Tumor Cells Revenue Market Forecast (2018-2023)
Figure Europe Circulating Tumor Cells Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Circulating Tumor Cells Revenue Market Forecast (2018-2023)
Figure South America Circulating Tumor Cells Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Circulating Tumor Cells Revenue Market Forecast (2018-2023)
  • Global Non-Melanoma Skin Cancer Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 17-Sep-2018        Price: US 3480 Onwards        Pages: 139
    Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Scope of the Report: This report studies the Non-Melanoma Skin Cancer market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Non-Melanoma Skin Cancer market by p......
  • 2018-2023 Global Bladder Cancer Therapeutics Market Report (Status and Outlook)
    Published: 10-Sep-2018        Price: US 4660 Onwards        Pages: 119
    In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Bladder Cancer Therapeutics market for 2018-2023. The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary system. Majority of bladder cancer develops in the innermost lay......
  • 2018-2023 Global Breast Cancer Monoclonal Antibodies Market Report (Status and Outlook)
    Published: 10-Sep-2018        Price: US 4660 Onwards        Pages: 155
    In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Breast Cancer Monoclonal Antibodies market for 2018-2023. Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protei......
  • Global Melanoma Partnering 2012 to 2018
    Published: 01-Sep-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Melanoma Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and ......
  • Global Multiple Myeloma Partnering 2012 to 2018
    Published: 01-Sep-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Multiple Myeloma Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understand......
  • Global Ovarian Cancer Partnering 2012 to 2018
    Published: 01-Sep-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Ovarian Cancer Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understandin......
  • Global Pancreatic Cancer Partnering 2012 to 2018
    Published: 01-Sep-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Pancreatic Cancer Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understan......
  • Global Prostate Cancer Partnering 2012 to 2018
    Published: 01-Sep-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Prostate Cancer Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understandi......
  • Global Solid Tumor Partnering 2012 to 2018
    Published: 01-Sep-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Solid Tumor Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs